In the clinic, gene expression analysis for breast cancer patients revealed that high SLPI was associated with a shorter time to tumor relapse and shorter overall survival [16], while the opposite correlation was reported for time to relapse using another dataset [33]; moreover, the levels and the role of SLPI expression in different breast cancer subtypes have not yet been systematically compared. The gene discussed is SLPI; the disease is neoplasm.